Yee-Sin Leo

National University of Singapore (NUS) - Department of Microbiology and Immunology

5 Science Drive 2 Blk MD4, Level 3

117545

Singapore

  • National University of Singapore (NUS) - Department of Microbiology and Immunology

SCHOLARLY PAPERS

11

DOWNLOADS
Rank 13,033

SSRN RANKINGS

Top 13,033

in Total Papers Downloads

7,238

SSRN CITATIONS

13

CROSSREF CITATIONS

2

Scholarly Papers (11)

Actions:
Email selected abstracts
1.

Clinical and Virological Features of SARS-CoV-2 Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.315 (Beta), and B.1.617.2 (Delta)

Number of pages: 24 Posted: 07 Jun 2021
Sean Wei Xiang Ong, Calvin J. Chiew, Li Wei Ang, Tze-Minn Mak, Lin Cui, Matthias Paul HS Toh, Yi Ding Lim, Pei Hua Lee, Tau Hong Lee, Po Ying Chia, Sebastian Maurer-Stroh, Raymond Tzer Pin Lin, Yee-Sin Leo, Vernon J. Lee, David Chien Lye and Barnaby E. Young
National Centre for Infectious Diseases, Singapore, National Centre for Infectious Diseases, Singapore, National Centre for Infectious Diseases, Singapore, National Centre for Infectious Diseases, Singapore, National Centre for Infectious Diseases, Singapore, National Centre for Infectious Diseases, Singapore, Ministry of Health, Singapore, National Centre for Infectious Diseases, Singapore, National Centre for Infectious Diseases, Singapore, National Centre for Infectious Diseases, Singapore, Agency for Science, Technology and Research (A*STAR) - Bioinformatics Institute, National Centre for Infectious Diseases, National University of Singapore (NUS) - Department of Microbiology and Immunology, Ministry of Health, Singapore, Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine and National Centre for Infectious Diseases, Singapore
Downloads 6,121 (2,514)
Citation 41

Abstract:

Loading...

COVID-19; SARS-CoV-2; B.1.1.7; B.1.351; B.1.617; variants of concern; severity; mortality

2.

Immunological and Viral Correlates of COVID-19 Disease Severity: A Prospective Cohort Study of the First 100 Patients in Singapore

Number of pages: 34 Posted: 20 May 2020
Barnaby E. Young, Sean Wei Xiang Ong, Lisa FP Ng, Danielle E. Anderson, Wan Ni Chia, Po Ying Chia, Li Wei Ang, Tze-Minn Mak, Shirin Kalimuddin, Louis Yi Ann Chai, Surinder Pada, Seow Yen Tan, Louisa Sun, Purmina Parthasarathy, Siew-Wai Fong, Yi-Hao Chan, Chee Wah Tan, Bernett Lee, Olaf Rötzschke, Ying Ding, Paul Tambyah, Jenny GH Low, Lin Cui, Timothy Barkham, Raymond Tzer Pin Lin, Yee-Sin Leo, Laurent Renia, Lin-Fa Wang, David Chien Lye and Singapore 2019 Novel Coronavirus Outbreak Research Team
National Centre for Infectious Diseases, Singapore, National Centre for Infectious Diseases, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Duke NUS Medical School, Duke-NUS Medical School - Programme in Emerging Infectious Diseases, National Centre for Infectious Diseases, Singapore, Ministry of Health, Singapore, National Centre for Infectious Diseases, Singapore, National University of Singapore (NUS) - Department of Infectious Diseases, National University Health System (NUHS), Ng Teng Fong General Hospital - Division of Infectious Diseases, Changi General Hospital, Alexandra Hospital, Khoo Teck Puat Hospital, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Duke NUS Medical School, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), National Centre for Infectious Diseases, National University of Singapore (NUS), National University of Singapore (NUS) - Singapore General Hospital, National Centre for Infectious Diseases, Singapore, Tan Tock Seng Hospital, National Centre for Infectious Diseases, National University of Singapore (NUS) - Department of Microbiology and Immunology, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Duke NUS Medical School, National Centre for Infectious Diseases and Independent
Downloads 605 (86,528)
Citation 5

Abstract:

Loading...

Coronavirus Disease 2019; COVID-19; severe acute respiratory syndrome coronavirus 2; SARS-CoV-2; severe; critical illness; IL-6; serology; viral culture

3.

Linear B-Cell Epitopes in the Spike and Nucleocapsid Proteins as Markers of SARS-CoV-2 Exposure and Disease Severity

Number of pages: 38 Posted: 12 Jun 2020
Siti Naqiah Amrun, Cheryl Yi-Pin Lee, Bernett Lee, Siew-Wai Fong, Barnaby E. Young, Rhonda Sin-Ling Chee, Nicholas Kim-Wah Yeo, Anthony Torres-Ruesta, Guillaume Carissimo, Chek Meng Poh, Zi Wei Chang, Matthew Zirui Tay, Yi-Hao Chan, Mark I-Cheng Chen, Paul A. Tambyah, Shirin Kalimuddin, Surinder Pada, Seow Yen Tan, Louisa Jin Sun, Yee-Sin Leo, David Chien Lye, Laurent Renia and Lisa FP Ng
Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), National Centre for Infectious Diseases, Singapore, Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), National Centre for Infectious Diseases, National Centre for Infectious Diseases, National University of Singapore (NUS) - Department of Infectious Diseases, Ng Teng Fong General Hospital - Division of Infectious Diseases, Changi General Hospital, Alexandra Hospital, National University of Singapore (NUS) - Department of Microbiology and Immunology, National Centre for Infectious Diseases, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN) and Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN)
Downloads 135 (404,786)
Citation 6

Abstract:

Loading...

epitopes; SARS-CoV-2; COVID-19; patients; biomarkers

4.

Comparison of the Clinical Features, Viral Shedding and Immune Response in Vaccine Breakthrough Infection by the Omicron and Delta Variants

Number of pages: 35 Posted: 24 Jun 2022
Sai Meng Tham, Siew‐Wai Fong, Zi-Wei Chang, Kai Sen Tan, Angeline Rouers, Yun Shan Goh, Douglas Jie Wen Tay, Sean Wei Xiang Ong, Ying Hao, Siang Li Chua, Jean-Marc Chavatte, Lin Cui, Matthew Zirui Tay, Raymond Tzer Pin Lin, Laurent Renia, Yee-Sin Leo, Justin Jang Hann Chu, David Chien Lye, Lisa F.P. Ng, Barnaby E. Young and PROTECT Cohort Study Group
National University of Singapore (NUS) - National University Hospital, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, National University of Singapore (NUS) - Department of Microbiology and Immunology, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, National University of Singapore (NUS) - Department of Microbiology and Immunology, National Centre for Infectious Diseases, Singapore, National Centre for Infectious Diseases, National Centre for Infectious Diseases, National Centre for Infectious Diseases, National Centre for Infectious Diseases, Singapore, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, National Centre for Infectious Diseases, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, National University of Singapore (NUS) - Department of Microbiology and Immunology, National University of Singapore (NUS) - Department of Microbiology and Immunology, Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, National Centre for Infectious Diseases, Singapore and Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs
Downloads 84 (565,053)

Abstract:

Loading...

COVID-19, SARS-CoV-2, Delta, Omicron, variants of concern, vaccine breakthrough

5.

Real-World Effectiveness of Sotrovimab and Remdesivir for Early Treatment of High-Risk Hospitalized COVID-19 Patients

Number of pages: 20 Posted: 08 Jul 2022
Lin Pin Koh, Siang Li Chua, Shawn Vasoo, Matthias Paul HS Toh, Jeremy Nicholas Cutter, Puay Hoon Nah, Yee-Sin Leo, Jun Xin Tay, Barnaby E. Young, David Chien Lye and Sean Wei Xiang Ong
National Centre for Infectious Diseases, National Centre for Infectious Diseases, National Centre for Infectious Diseases, National Centre for Infectious Diseases, Singapore, National Centre for Infectious Diseases, National Centre for Infectious Diseases, National University of Singapore (NUS) - Department of Microbiology and Immunology, National Centre for Infectious Diseases, National Centre for Infectious Diseases, Singapore, Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine and National Centre for Infectious Diseases
Downloads 81 (577,336)

Abstract:

Loading...

COVID-19, SARS-CoV-2, early-treatment, sotrovimab, remdesivir, high-risk

6.

Prolonged Inflammation in COVID-19 Survivors Resolves 2 Years After Coronavirus Disease 2019 (COVID-19)

Number of pages: 48 Posted: 27 Jun 2022
Siew‐Wai Fong, Yun Shan Goh, Anthony Torres-Ruesta, Zi Wei Chang, Yi-Hao Chan, Vanessa Kexin Neo, Bernett Lee, Kaibo Duan, Siti Naqiah Amrun, Nicholas Kim‐Wah Yeo, Matthew Zirui Tay, Guillaume Carissimo, COVID-19 Study Group, NCID Study Group, Seow-Yen Tan, Yee-Sin Leo, David Chien Lye, Laurent Renia, Barnaby E. Young and Lisa F.P. Ng
Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Independent, Independent, Changi General Hospital - Department of Infectious Diseases, National University of Singapore (NUS) - Department of Microbiology and Immunology, Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, National Centre for Infectious Diseases, Singapore and Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs
Downloads 68 (635,955)

Abstract:

Loading...

Long COVID, inflammation, subclinical signs, COVID vaccine

7.

Association of SARS-CoV-2 Clades with Clinical, Inflammatory and Virologic Outcomes: An Observational Study

Number of pages: 33 Posted: 05 Jan 2021
Barnaby E. Young, Wycliffe E. Wei, Siew-Wai Fong, Tze-Minn Mak, Danielle E. Anderson, Yi-Hao Chan, Rachael Pung, Cheryl SY Heng, Li Wei Ang, Kang Eng Zheng, Bernett Lee, Shirin Kalimuddin, Surinder Pada, Paul A. Tambyah, Purnima Parthasarathy, Seow-Yen Tan, Louisa Sun, Gavin JD Smith, Raymond Tzer Pin Lin, Yee-Sin Leo, Laurent Renia, Lin-Fa Wang, Lisa F.P. Ng, Sebastian Maurer-Stroh, David Chien Lye and Vernon J. Lee
National Centre for Infectious Diseases, Singapore, National Public Health and Epidemiology Unit, National Centre for Infectious Diseases, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), National Centre for Infectious Diseases, Singapore, Duke NUS Medical School, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Government of the Republic of Singapore - Communicable Diseases Division, Ministry of Health, Singapore, National Centre for Infectious Diseases, Singapore, Duke NUS Medical School, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), National University of Singapore (NUS) - Department of Infectious Diseases, Ng Teng Fong General Hospital - Division of Infectious Diseases, National University Health System, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Khoo Teck Puat Hospital, Changi General Hospital - Department of Infectious Diseases, Alexandra Hospital, Duke-NUS Medical School, National Centre for Infectious Diseases, National University of Singapore (NUS) - Department of Microbiology and Immunology, Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, Duke NUS Medical School, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Bioinformatics Institute, Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine and Ministry of Health, Singapore
Downloads 56 (699,401)

Abstract:

Loading...

8.

Immune Landscape of 382-Nt Deleted SARS-CoV-2 Reveals Heightened Adaptive Response Indicating Prophylactic Potential Against COVID-19

Number of pages: 90 Posted: 21 Oct 2020
Siew-Wai Fong, Nicholas Kim-Wah Yeo, Yi-Hao Chan, Yun Shan Goh, Siti Naqiah Amrun, Nicholas Ang, Josephine Lum, Shihui Foo, Cheryl Yi-Pin Lee, Guillaume Carissimo, Rhonda Sin-Ling Chee, Anthony Torres-Ruesta, Matthew Zirui Tay, Zi Wei Chang, Chek Meng Poh, Barnaby E. Young, Paul A. Tambyah, Shirin Kalimuddin, Yee-Sin Leo, David Chien Lye, Bernett Lee, Subhra Biswas, Shanshan W. Howland, Laurent Renia and Lisa F.P. Ng
Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, National Centre for Infectious Diseases, Singapore, National Centre for Infectious Diseases, National University of Singapore (NUS) - Department of Infectious Diseases, National University of Singapore (NUS) - Department of Microbiology and Immunology, Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN) and Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN)
Downloads 29 (893,687)

Abstract:

Loading...

COVID-19, SARS-CoV-2, transcriptome, ORF8, deletion, RNA-seq

9.

SARS-CoV-2 Infection Generates Long-Lived Memory B Cells Against the Receptor Binding Domain of the Spike Protein

Number of pages: 41 Posted: 14 Dec 2021
Angeline Rouers, Matthew Zirui Tay, Siew‐Wai Fong, Yun Shan Goh, Zi Wei Chang, Siti Naqiah Amrun, Nicholas Kim‐Wah Yeo, Yuling Huang, Pei Xiang Hor, Chiew Yee Loh, Yi-Hao Chan, Guillaume Carissimo, Jackwee Lim, Weili Xu, Kaibo Duan, Menaka P. Rajapakse, Wang Bei, Eve Ngoh, Chia Yin Lee, Siti Nazihah Mohd Salleh, Paul A. MacAry, Cheng-I Wang, Bernett Lee, Olaf Rotzschke, Seow-Yen Tan, Barnaby E. Young, Yee-Sin Leo, David Chien Lye, Lisa F.P. Ng and Laurent Renia
Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), National University of Singapore (NUS) - Department of Microbiology and Immunology, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Changi General Hospital - Department of Infectious Diseases, National Centre for Infectious Diseases, Singapore, National University of Singapore (NUS) - Department of Microbiology and Immunology, Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs and Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs
Downloads 21 (971,148)

Abstract:

Loading...

antibodies, memory B cells, SARS-COV-2, COVID-19, severity, RBD, spike protein, long-lived

10.

Sensitive Detection of Total Anti-Spike Antibodies and Isotype Switching in Asymptomatic and Symptomatic COVID-19 Patients

Number of pages: 44 Posted: 23 Oct 2020
Yun Shan Goh, Jean-Marc Chavatte, Alicia Lim Jieling, Bernett Lee, Siti Naqiah Amrun, Cheryl Yi-Pin Lee, Rhonda Sin-Ling Chee, Bei Wang, Chia Yin Lee, Eve Ngoh, Cheng-I Wang, Barnaby E. Young, Paul A. Tambyah, Shirin Kalimuddin, Surinder Pada, Seow-Yen Tan, Louisa Sun, Mark I-Cheng Chen, Yee-Sin Leo, David Chien Lye, Lisa F.P. Ng, Raymond Tzer Pin Lin and Laurent Renia
Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, National Centre for Infectious Diseases, National Centre for Infectious Diseases, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), National Centre for Infectious Diseases, Singapore, National Centre for Infectious Diseases, National University of Singapore (NUS) - Department of Infectious Diseases, Ng Teng Fong General Hospital - Division of Infectious Diseases, Changi General Hospital - Department of Infectious Diseases, Alexandra Hospital, National Centre for Infectious Diseases, National University of Singapore (NUS) - Department of Microbiology and Immunology, Nanyang Technological University (NTU) - Lee Kong Chian School of Medicine, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), National Centre for Infectious Diseases and Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre
Downloads 20 (981,411)
Citation 2

Abstract:

Loading...

SARS-CoV-2, COVID-19, serological, S protein, antibodies, IgG subclasses, symptomatic, asymptomatic

11.

CD27 hiCD38 hi Plasmablasts are Activated B Cells of Mixed Origin with Distinct Function

Number of pages: 48 Posted: 08 Jul 2020
Angeline Rouers, Ramapraba Appanna, Marion Chevrier, Josephine Lum, MaiChan Lau, Lingqiao Tan, Alicia Tay, Durgalakshmi Sathiakumar, Kaval Kaur, Julia Boehme, Yee-Sin Leo, Shanshan W. Howland, Amit Singhal, Jinmiao Chen and Katja Fink
Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), National University of Singapore (NUS) - Department of Microbiology and Immunology, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN) and Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN)
Downloads 18 (1,002,777)

Abstract:

Loading...

plasmablasts, viral infection, antibodies, single cell RNAseq, dengue, B cell memory, antibody-secreting cells